HRMY
Harmony Biosciences Holdings
NASDAQ: HRMY · HEALTHCARE · BIOTECHNOLOGY
$31.26
+0.68% today
Updated 2026-04-30
Market cap
$1.80B
P/E ratio
11.46
P/S ratio
2.07x
EPS (TTM)
$2.71
Dividend yield
—
52W range
$26 – $41
Volume
1.0M
Harmony Biosciences Holdings (HRMY) Financial statements
SEC filings — annual and quarterly data.
Cash flow — annual
| Item | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|---|---|---|
| Operating cash flow | $-38.80M | $-75.44M | $-2.98M | $98.56M | $144.47M | $219.39M | $219.82M | $348.20M |
| Capital expenditures | $1.34M | $149000.00 | $2.00M | $298000.00 | $172000.00 | $312000.00 | $1.15M | $310000.00 |
| Depreciation | $184000.00 | $3.80M | $10.24M | $21.08M | $25.05M | $24.36M | $24.11M | — |
| Stock-based comp | $1.08M | $9.91M | $4.69M | $16.11M | $26.91M | $31.70M | $42.60M | $44.90M |
| Free cash flow | $-40.14M | $-75.58M | $-4.99M | $98.26M | $144.29M | $219.07M | $218.67M | $347.89M |
| Investing cash flow | $-1.34M | $-127.15M | $-2.00M | $-100.30M | $-141.83M | $-46.44M | $-67.48M | — |
| Financing cash flow | $21.61M | $143.77M | $209.16M | $7.42M | $6.84M | $-105.55M | $-11.00M | — |
| Dividends paid | — | $143.77M | $200.30M | — | — | $5.05M | — | — |
| Share repurchases | — | — | — | — | — | — | — | — |
| Debt repayment | — | — | — | — | — | — | — | — |
| Net change in cash | — | — | $204.17M | $5.68M | $9.47M | — | — | — |